A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial-Reference-Cited by-同舟云学术

A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial

Published:2020-03-31 Issue:5 Volume:190 Page:736-740
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Offner Fritz¹,Robak Tadeusz²,Janssens Ann³,Govind Babu K.⁴,Kloczko Janusz⁵,Grosicki Sebastian⁶,Mayer Jiri⁷,Panagiotidis Panagiotis⁸,Schuh Anna⁹,Pettitt Andrew¹⁰,Montillo Marco¹¹,Werner Olena¹²,Vincent Ghislaine¹³,Khanna Sadhvi¹³,Hillmen Peter¹⁴

Affiliation:

1. Department of Hematology University Hospital Ghent Gent Belgium

2. Department of Haematology Medical University of Lodz Lodz Poland

3. Universitaire Ziekenhuizen Leuven Leuven Belgium

4. Department of Medical Oncology Kidwai Memorial Institute of Oncology HCG Hospitals Bangalore India

5. Department of Hematology Medical University of Bialystok Bialystok Poland

6. Medical University of Silesia Katowice Poland

7. Department of Internal Medicine, Haematology and Oncology Masaryk University Hospital Brno Brno Czech Republic

8. Haematology Department Department of Internal Medicine University of Athens Laikon General Hospital National and Kapodistrian University of Athens Medical School Athens Greece

9. Department of Oncology University of Oxford Oxford UK

10. University of Liverpool Liverpool UK

11. Department of Haematology Niguarda Cancer Center Niguarda Hospital Milan Italy

12. Novartis Pharma AG Basel Switzerland

13. Novartis Pharma S.A.S Paris France

14. Department of Haematology St James's University Hospital Leeds UK

Funder

Novartis

Publisher

Wiley

Subject

Hematology